Founded in South San Francisco, Enable Biosciences is a diagnostics company focused on developing ultrasensitive immunoassays for the early detection and treatment of autoimmune and infectious diseases. Spun out of UC Berkeley and Stanford, the company aims to create precision medicine tools that can predict and diagnose diseases at their earliest stages. Their products are designed for use in healthcare settings to improve patient outcomes through timely intervention.
Enable Biosciences has notable affiliations with prestigious institutions such as Stanford Healthcare, Harvard Medical School, and the California Department of Public Health. They have also collaborated with organizations like JDRF. The company has performed over a significant number of tests, demonstrating their impact in the field of predictive medicine. Their innovative approach has positioned them as a key player in the diagnostics industry, contributing to advancements in early disease detection and patient care.
